楚天科技1月9日获融资买入8131.04万元，融资余额3.42亿元

Group 1 - The core viewpoint of the news is that Chutian Technology experienced a significant increase in stock price and trading volume, indicating strong investor interest and activity in the market [1] - On January 9, Chutian Technology's stock rose by 5.81%, with a trading volume of 592 million yuan, and a net financing purchase of 20.49 million yuan [1] - As of January 9, the total margin balance for Chutian Technology reached 342 million yuan, accounting for 4.25% of its market capitalization, which is above the 90th percentile of the past year [1] Group 2 - Chutian Technology, established on November 8, 2002, and listed on January 21, 2014, specializes in pharmaceutical equipment and comprehensive technical solutions [2] - The company's revenue composition includes: detection packaging solutions (24.88%), parts and after-sales service (16.44%), biological engineering solutions (14.84%), and other segments [2] - For the period from January to September 2025, Chutian Technology reported a revenue of 3.896 billion yuan, a year-on-year decrease of 6.60%, while net profit attributable to shareholders increased by 145.11% to 84.4635 million yuan [2] Group 3 - Chutian Technology has distributed a total of 361 million yuan in dividends since its A-share listing, with 117 million yuan distributed over the past three years [3] - As of September 30, 2025, the number of shareholders increased by 4.10% to 28,900, while the average circulating shares per person decreased by 3.94% to 19,913 shares [2][3] - Among the top ten circulating shareholders, Hong Kong Central Clearing Limited holds 9.3865 million shares, a decrease of 800,600 shares from the previous period, while a new shareholder, Anxin Medical Health Stock A, holds 1.7338 million shares [3]